ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Second Phase 3 Study Results for LMTX® Published in the Journal of Alzheimer's Disease
November 27, 2017TauRx Therapeutics Ltd today reported the full results from its second Phase 3 clinical study of LMTX®, the first tau aggregation inhibitor in Alzheimer's disease, published online in the Journal of Alzheimer's Disease. -
New Gates Foundation Report Highlights Remarkable Progress Against Global Poverty and Disease, Warns
The Bill & Melinda Gates Foundation today launched an inaugural annual report showcasing the remarkable progress that has been made in reducing extreme poverty and disease in recent decades
-
Ocalvia gets NHS green light for rare chronic liver disease
April 28, 2017Intercept's Ocaliva has been issued a final green light for use by the NHS to treat the rare chronic liver disease primary ... -
RGC, UK Biobank and GSK launch new initiative to improve disease diagnosis
March 27, 2017Regeneron Genetics Center (RGC), UK Biobank and GSK have launched a gene sequencing initiative on the world's detailed health database.
Pharma Sources Insight January 2025
